Abstract
Tuberculosis is an important health problem in developing countries and the BCG vaccine plays an important part in preventing the disease. There are different reports about the preventive value of BCG. Some of them claim that it is satisfactory while others suggest that it provides little protection. There are also varying ideas about the optimum time to vaccinate babies, some studies suggesting that late vaccination confers a high degree of protection. This prospective controlled study has been undertaken to evaluate the value of BCG vaccine given to babies during their first three days of life versus its value when given in their third month of life. Evaluation was measured by the results of tests with purified protein derivative (PPD), by vaccine scars, that by the complications of the vaccine. It was found that BCG given at the end of the third month provides a higher rate of response and fewer complications than when given during the first three days of life.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clemens J. D., Chuong J. J., Feinstein A. R. The BCG controversy. A methodological and statistical reappraisal. JAMA. 1983 May 6;249(17):2362–2369. [PubMed] [Google Scholar]
- Comstock G. W., Palmer C. E. Long-term results of BCG vaccination in the southern United States. Am Rev Respir Dis. 1966 Feb;93(2):171–183. doi: 10.1164/arrd.1966.93.2.171. [DOI] [PubMed] [Google Scholar]
- Grindulis H., Baynham M. I., Scott P. H., Thompson R. A., Wharton B. A. Tuberculin response two years after BCG vaccination at birth. Arch Dis Child. 1984 Jul;59(7):614–619. doi: 10.1136/adc.59.7.614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Houston S., Fanning A., Soskolne C. L., Fraser N. The effectiveness of bacillus Calmette-Guérin (BCG) vaccination against tuberculosis. A case-control study in Treaty Indians, Alberta, Canada. Am J Epidemiol. 1990 Feb;131(2):340–348. doi: 10.1093/oxfordjournals.aje.a115503. [DOI] [PubMed] [Google Scholar]
- Price J. F. BCG vaccination. Arch Dis Child. 1982 Jul;57(7):485–486. doi: 10.1136/adc.57.7.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- STEIN S. C., ARONSON J. D. The occurrence of pulmonary lesions in BCG-vaccinated and unvaccinated persons. Am Rev Tuberc. 1953 Nov;68(5):695–712. doi: 10.1164/art.1953.68.5.695. [DOI] [PubMed] [Google Scholar]
- Tidjani O., Amedome A., ten Dam H. G. The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. Tubercle. 1986 Dec;67(4):269–281. doi: 10.1016/0041-3879(86)90016-4. [DOI] [PubMed] [Google Scholar]
- Victoria M. S., Shah B. R. Bacillus Calmette-Guérin lymphadenitis: a case report and review of the literature. Pediatr Infect Dis. 1985 May-Jun;4(3):295–296. [PubMed] [Google Scholar]
